Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion type Assertion NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_head.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion description "[Perfusion with the ATP-sensitive K(+) channel (K(ATP)) inhibitor glibenclamide (GLIB) or the mitochondrial K(ATP) (mitoK(ATP)) inhibitor 5-hydroxydecanoate (5-HD) for 20 minutes before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion evidence source_evidence_literature NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion SIO_000772 15256482 NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion wasDerivedFrom befree-20150227 NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion wasGeneratedBy ECO_0000203 NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.